Drug Shortage Report for M-M-R II

Last updated on 2017-05-15 History
Report ID 4420
Drug Identification Number 00466085
Brand name M-M-R II
Common or Proper name (measles, mumps and rubella virus vaccine, live, attenuated) Lyophilized powder for injection
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) MEASLES VIRUS VACCINE LIVE ATTENUATED; MUMPS VIRUS VACCINE LIVE ATTENUATED (JERYL LYNN STRAIN); RUBELLA VIRUS VACCINE LIVE ATTENUATED (WISTAR RA27/3 STRAIN)
Strength(s) 0.5 mL dose after reconstitution Measles: ≥1000 CCID50 Mumps: ≥5000 CCID50 Rubella: ≥1000 CCID50
Dosage form(s) Powder For Solution
Route of administration Subcutaneous
Packaging size 10x1dose
ATC code J07BD
ATC description VIRAL VACCINES
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2017-05-10
Actual start date 2017-05-11
Estimated end date 2017-05-20
Actual end date 2017-05-12
Shortage status Resolved
Updated date 2017-05-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2017-05-15 French Compare
v14 2017-05-15 English Compare
v13 2017-05-12 English Compare
v12 2017-05-11 English Compare
v11 2017-05-11 English Compare
v10 2017-05-05 English Compare
v9 2017-05-02 English Compare
v8 2017-04-10 English Compare
v7 2017-04-10 French Compare
v6 2017-04-10 French Compare
v5 2017-04-10 English Compare
v4 2017-03-27 French Compare
v3 2017-03-27 English Compare
v2 2017-03-27 English Compare
v1 2017-03-27 English Compare

Showing 1 to 15 of 15